Monday: Prostate cancer radiotherapy
Following the practice-changing results of CHHiP, moderate hypofractionation has become standard of care for intermediate prostate cancer. There is huge interest in extreme hypofractionation, with trial results awaited, and how to improve outcomes for higher-risk disease - either by intensifying radiotherapy or adding in systemic agents.
As men live longer, salvage options following surgery, focal therapy and even external-beam radiotherapy are increasingly being considered.
Professor Hahn will talk in the general meeting about proton beam therapy; the prostate session will continue with talks on other technical advances that may alter the management of our patients: the MRI linac and SABR for oligometastatic disease. The outlining workshop will aim to address both commonly asked questions and newer concepts such as sub-volume boosting.
Session organiser: Dr John Staffurth
Tuesday: Pelvic re-irradiation
Radiotherapy techniques have changed significantly in recent years and as such we’re now in a position to consider re-irradiation. We will briefly consider some general concepts of re-irradiation before focusing on different strategies for radical re-irradiation in prostate cancer including external beam and brachytherapy. Over the course of the day, the use of SABR in a previously irradiated pelvis will be summarised and Professor Hahn will highlight the potential for protons in this setting.
The afternoon session will focus on rectal cancer with Professor Rutten describing re-irradiation prior to definitive surgery, followed by presentation and discussion of case studies.
Session organiser: Dr Rebecca Muirhead
Wednesday: Lower GI
This session will focus on radiotherapy for rectal cancer. We will review the emerging evidence for organ preservation strategies in rectal cancer both in routine clinical practice and in future clinical trials. Future trials will assess the benefits of intensification of treatment either using additional therapies or dose escalation.
We will also review the emerging landscape of stratified medicine in rectal cancer. We will include two sessions on case presentations with an emphasison audience participation. The contouring session will address risk adapted target volume definition.
Session organiser: Professor David Sebag-Montefoire
Radiotherapy outling workshops
As part of the main lecture streams on Monday and Wednesday, session organisers will host radiotherapy outlining workshops.
Monday will cover standard prostate treatment, focal boosting (for PIVOTAL boost) and pelvic nodal radiotherapy (for PIVOTAL boost); and Wednesday will focus on rectal cancer.
Please note that these outlining workshops will use the RCR radiotherapy outlining platform and will involve preregistration and a small amount of work to be done in advance of the meeting, so please do ensure this session is selected when registering for RCR18. Delegates must bring their own laptops.
CO and CR academic workshop
Chairs: Professor Peter Hoskin and Professor Vicky Goh
Multidisciplinary session with contributions from a consultant clinical oncologist, radiologist, physicist and a patient representative who has been involved in imaging studies.
Developing educators in oncology and radiology
Chair: Dr Pat Set
This workshop provides knowledge on curriculum development and assessment. Lived experience is shared by those who have undertaken taught courses in Medical Education.
RCR18 - CO programme